Based on cell surface hormone receptors, breast cancer can be divided into 4 subtypes: Luminal A-estrogen receptor positive (ER+), Luminal B-progesterone receptor positive (PR+), human epidermal growth factor receptor 2 positive (HER2+), and triple-negative breast cancer (TNBC). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.